Valeant Pharmaceuticals agrees to acquire Ortho Dermatologics
MLex Summary: Valeant Pharmaceuticals has announced that it will acquire the Ortho Dermatologics division of Janssen Pharmaceuticals for $345 million. The transaction is subject to regulatory approvals and is expected to...To view the full article, register now.
Already a subscriber? Click here to view full article